{
    "Trade/Device Name(s)": [
        "Xpert\u00ae Xpress GBS",
        "Xpert Xpress GBS",
        "GeneXpert\u00ae Dx System",
        "GeneXpert\u00ae Infinity Systems"
    ],
    "Submitter Information": "Cepheid",
    "510(k) Number": "K222638",
    "Predicate Device Reference 510(k) Number(s)": [
        "K060540"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "NJR",
        "OOI"
    ],
    "Summary Letter Date": "September 27, 2023",
    "Summary Letter Received Date": "September 1, 2022",
    "Submission Date": "August 31, 2022",
    "Regulation Number(s)": [
        "21 CFR 866.3740",
        "21 CFR 862.2570"
    ],
    "Regulation Name(s)": [
        "Streptococcus spp. serological reagents",
        "Instrumentation for clinical multiplex test systems"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Group B Streptococcus (GBS) DNA"
    ],
    "Specimen Type(s)": [
        "Vaginal/rectal swab"
    ],
    "Specimen Container(s)": [
        "Cepheid Collection Device (Catalog 900-0370)"
    ],
    "Instrument(s)/Platform(s)": [
        "GeneXpert\u00ae Instrument Systems",
        "GeneXpert Dx",
        "GeneXpert Infinity-48s",
        "GeneXpert Infinity-80"
    ],
    "Method(s)/Technology(ies)": [
        "Qualitative real-time polymerase chain reaction (PCR)",
        "Nucleic acid amplification",
        "Automated sample preparation and detection"
    ],
    "Methodologies": [
        "Real-time PCR",
        "Molecular detection"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Cartridge",
        "Instrument",
        "Collection device"
    ],
    "Document Summary": "FDA 510(k) summary for Cepheid Xpert Xpress GBS test using real-time PCR on GeneXpert platforms for qualitative detection of Group B Streptococcus DNA from vaginal/rectal swabs in pregnant patients at intrapartum.",
    "Indications for Use Summary": "Qualitative detection of Group B Streptococcus (GBS) DNA from vaginal/rectal swabs collected from pregnant patients at term for intrapartum testing to aid in identifying GBS colonization in those with unknown or unavailable antepartum screening and no additional risk factors for empiric antibiotic prophylaxis.",
    "fda_folder": "Microbiology"
}